C92.4

Applicable To

• AML M3

• AML Me with t 15;17) and variants

Clinical Information

• An acute myeloid leukemia aml) in which abnormal promyelocytes predominate. It is characterized by the t 15;17) q22;q12) translocation. There are two variants: the typical and microgranular variant. This aml is particularly sensitive to treatment with all trans-retinoic acid and has a favorable prognosis. who, 2001)

• An acute myeloid leukemia in which abnormal promyelocytes predominate. It is frequently associated with disseminated intravascular coagulation.

• An aggressive fast-growing) type of acute myeloid leukemia in which there are too many immature blood-forming cells in the blood and bone marrow. It is usually marked by an exchange of parts of chromosomes 15 and 17.

Details

• C92.4 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.

• The 2023 edition of ICD-10-CM C92.4 became effective on October 1, 2022.

• This is the American ICD-10-CM version of C92.4 – other international versions of ICD-10 C92.4 may differ.